IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of Inb-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting
IN8bio在2024年美國血液學會年會上報告了Inb-100異源γ-δ T細胞對白血病的1期研究持續無進展生存情況。
